Delivering Guidelines for COPD and Pharma Partnership Dr Ninian Hewitt

advertisement
Delivering Guidelines for COPD
and
Pharma Partnership
Dr Ninian Hewitt
Clinical Lead for Lothian
Respiratory (COPD) MCN
Lothian COPD Guidelines
Why?
• Patients needed better care and
healthcare professionals needed
concise and up-to-date information
• Outcome – Patients with COPD will
receive the best possible care
Lothian COPD Guidelines
Who?
• Patients and carers were involved from the beginning.
They gave their opinions and advice about:
– The treatment they would like
– Issues they felt needed to be addressed
– Terminology discrepancies
• We also consulted a wide range of healthcare
professionals including consultants, pharmacists,
physiotherapists, physiologists, specialist nurses, GPs,
stop smoking facilitators and many more
Lothian COPD Guidelines
What?
•
•
•
•
•
•
•
•
•
•
•
Diagnosis
Risk factors
Chest x-ray
A1 antitrypsin deficiency
Co-morbidities
Treatment
Delivery systems
Pulmonary rehabilitation
Exacerbations
Referral to consultant
Discharge and follow-up
•
•
•
•
•
•
•
•
Palliative care
Travelling with COPD
Help agencies for patients
and carers
Patient information
Contact information
Primary care exacerbation
protocol
Pulmonary rehabilitation
referral form
COPD self-management
plan
Lothian COPD Guidelines
•
•
•
•
Lothian wide
Includes an FAQ section
Based on GOLD definitions
Equality and diversity rapid impact
assessment performed
Lothian COPD Guidelines
How?
• Meetings were held in each CHP to introduce the
guidelines along with educational sessions on
spirometry and treatment. These were attended by
almost 200 healthcare professionals
• Secondary care meetings will be held in each of the
three main hospitals to discuss the guidelines
• An audit will be performed in 2010
Partnership with ABPI Scotland
• Guided by the Scottish Executive document A
Common Understanding – Guidance on Joint
Working Between NHS Scotland and the
Pharmaceutical Industry
• Participating under the umbrella of ABPI
Scotland; AstraZeneca, Boehringer Ingelheim,
Chiesi, GlaxoSmithKline, and Pfizer
Partnership with ABPI Scotland
• Monthly meetings held between ABPI companies
and MCN management
• ABPI companies offer support and resources but do
not make decisions for the MCN
• ABPI companies have no input in treatment
recommendations
• They have been extremely helpful with event
organising, social marketing and project managing
Other achievements…
Lothian Respiratory (COPD) MCN
Thank you
Download